{
    "output": {
        "input_text": "PET-CT BrainMemory loss, rule out Alzheimer\u2019s diseaseFindings:\nCerebral Metabolism: Reduced FDG uptake in the parietotemporal lobes bilaterally, more prominent on the left side, consistent with Alzheimer\u2019s disease.\nOther Findings: No significant tracer uptake in extra-cerebral structures.\nBackground Activity: Normal tracer uptake in the basal ganglia and cerebellum.\n\nImpression:\nFindings suggestive of early Alzheimer\u2019s disease.\nRecommend clinical correlation and neurocognitive testing.",
        "keywords": [
            "neurocognitive",
            "neurocognitive test",
            "Metabolism",
            "Impression",
            "Compression",
            "Alzheimer",
            "Cerebral",
            "Cerebra",
            "Findings",
            "Finding",
            "cerebral",
            "Activity",
            "Reduced",
            "ganglia",
            "testing",
            "t testing",
            "uptake",
            "tracer",
            "Normal",
            "lobes",
            "Other",
            "Others",
            "rule",
            "pet",
            "Cerebellum",
            "Neocerebellum",
            "cerebellum",
            "Bextra",
            "Clinical",
            "h disease",
            "disease"
        ],
        "text": "```json\n{\n  \"terms\": [\n    {\n      \"term\": \"neurocognitive\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Refers to the functioning of the nervous system, particularly concerning higher-order thinking and behavior.\",\n      \"relevance\": \"In medical imaging, neurocognitive tests are used to assess cognitive functions such as memory, language, and problem-solving skills.\",\n      \"relation\": \"The report recommends clinical correlation and neurocognitive testing to support the impression of early Alzheimer's disease.\"\n    },\n    {\n      \"term\": \"neurocognitive test\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"A standardized assessment used to evaluate cognitive functions, often used in conjunction with medical imaging.\",\n      \"relevance\": \"The report suggests that neurocognitive testing would be useful in confirming the diagnosis of Alzheimer's disease.\",\n      \"relation\": \"See above.\"\n    },\n    {\n      \"term\": \"Metabolism\",\n      \"category\": \"Biological process\",\n      \"explanation\": \"The processes by which organisms convert energy and resources to sustain life.\",\n      \"relevance\": \"In medical imaging, changes in cerebral metabolism can indicate various conditions, including Alzheimer's disease.\",\n      \"relation\": \"The report notes reduced FDG uptake in the parietotemporal lobes bilaterally.\"\n    },\n    {\n      \"term\": \"Impression\",\n      \"category\": \"Medical diagnosis\",\n      \"explanation\": \"A conclusion or diagnosis based on medical findings, often used to guide further testing and treatment.\",\n      \"relevance\": \"The report provides an impression of early Alzheimer's disease based on the imaging findings.\",\n      \"relation\": \"See below.\"\n    },\n    {\n      \"term\": \"Compression\",\n      \"category\": \"Medical condition\",\n      \"explanation\": \"A force applied to a body part, often resulting in tissue damage or injury.\",\n      \"relevance\": \"Not directly related to the report's findings.\",\n      \"relation\": \"None\"\n    },\n    {\n      \"term\": \"Alzheimer\",\n      \"category\": \"Medical condition\",\n      \"explanation\": \"A progressive neurodegenerative disorder causing memory loss and cognitive decline.\",\n      \"relevance\": \"The report suggests that the imaging findings are consistent with early Alzheimer's disease.\",\n      \"relation\": \"See below.\"\n    },\n    {\n      \"term\": \"Cerebral\",\n      \"category\": \"Anatomical region\",\n      \"explanation\": \"Relating to or affecting the brain.\",\n      \"relevance\": \"The report notes reduced FDG uptake in the cerebral lobes bilaterally.\",\n      \"relation\": \"See below.\"\n    },\n    {\n      \"term\": \"Cerebra\",\n      \"category\": \"Synonym for Cerebral\",\n      \"explanation\": \"Not a distinct term, but an alternative spelling or form of 'cerebral'.\",\n      \"relevance\": \"None\"\n    },\n    {\n      \"term\": \"Findings\",\n      \"category\": \"Imaging results\",\n      \"explanation\": \"The observed results from medical imaging studies.\",\n      \"relevance\": \"The report presents various findings, including reduced FDG uptake and normal tracer activity in the basal ganglia.\",\n      \"relation\": \"See below.\"\n    },\n    {\n      \"term\": \"Finding\",\n      \"category\": \"Synonym for Findings\",\n      \"explanation\": \"Not a distinct term, but an alternative form of 'findings'.\",\n      \"relevance\": \"None\"\n    },\n    {\n      \"term\": \"cerebral\",\n      \"category\": \"Anatomical region (duplicate)\",\n      \"explanation\": \"See above.\",\n      \"relevance\": \"See above.\"\n    },\n    {\n      \"term\": \"Activity\",\n      \"category\": \"Biological process\",\n      \"explanation\": \"The processes by which organisms function and sustain life.\",\n      \"relevance\": \"In medical imaging, changes in activity can indicate various conditions, including Alzheimer's disease.\",\n      \"relation\": \"The report notes normal tracer uptake in the basal ganglia and cerebellum.\"\n    },\n    {\n      \"term\": \"Reduced\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Decreased or diminished in quantity or quality.\",\n      \"relevance\": \"In medical imaging, reduced FDG uptake can indicate various conditions, including Alzheimer's disease.\",\n      \"relation\": \"The report notes reduced FDG uptake in the parietotemporal lobes bilaterally.\"\n    },\n    {\n      \"term\": \"ganglia\",\n      \"category\": \"Anatomical region\",\n      \"explanation\": \"Collections of nerve cell bodies located outside the central nervous system.\",\n      \"relevance\": \"The report notes normal tracer uptake in the basal ganglia.\",\n      \"relation\": \"See below.\"\n    },\n    {\n      \"term\": \"testing\",\n      \"category\": \"Medical procedure\",\n      \"explanation\": \"A process used to assess or evaluate a patient's condition.\",\n      \"relevance\": \"The report recommends neurocognitive testing to support the impression of early Alzheimer's disease.\",\n      \"relation\": \"See above.\"\n    },\n    {\n      \"term\": \"uptake\",\n      \"category\": \"Imaging finding\",\n      \"explanation\": \"A measurement or assessment used in medical imaging, often related to the accumulation or distribution of a tracer substance.\",\n      \"relevance\": \"The report notes reduced FDG uptake and normal tracer activity in various regions.\",\n      \"relation\": \"See above.\"\n    },\n    {\n      \"term\": \"tracer\",\n      \"category\": \"Imaging agent\",\n      \"explanation\": \"A substance used in medical imaging to highlight or visualize specific tissues or structures within the body.\",\n      \"relevance\": \"The report uses FDG as a tracer substance in PET-CT imaging.\",\n      \"relation\": \"See above.\"\n    },\n    {\n      \"term\": \"Normal\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Within the expected range or standard for a particular condition or measurement.\",\n      \"relevance\": \"The report notes normal tracer uptake in the basal ganglia and cerebellum.\",\n      \"relation\": \"See above.\"\n    },\n    {\n      \"term\": \"lobes\",\n      \"category\": \"Anatomical region\",\n      \"explanation\": \"A division of a larger organ or structure, often used to describe the brain's hemispheres (e.g., parietotemporal lobes).\",\n      \"relevance\": \"The report notes reduced FDG uptake in the parietotemporal lobes bilaterally.\",\n      \"relation\": \"See above.\"\n    },\n    {\n      \"term\": \"Other\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Used to describe or indicate anything not specifically mentioned elsewhere.\",\n      \"relevance\": \"The report notes 'no significant tracer uptake in extra-cerebral structures' under the heading of 'other findings'.\",\n      \"relation\": \"See above.\"\n    },\n    {\n      \"term\": \"rule\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"A principle or standard used to guide decision-making or assessment.\",\n      \"relevance\": \"The report notes that Alzheimer's disease should be 'ruled out' based on the imaging findings.\",\n      \"relation\": \"See above.\"\n    },\n    {\n      \"term\": \"pet\",\n      \"category\": \"Imaging modality\",\n      \"explanation\": \"Positron emission tomography, a type of medical imaging used to visualize and assess metabolic activity within the body.\",\n      \"relevance\": \"The report uses PET-CT imaging to evaluate cerebral metabolism.\",\n      \"relation\": \"See above.\"\n    },\n    {\n      \"term\": \"Cerebellum\",\n      \"category\": \"Anatomical region\",\n      \"explanation\": \"A division of the brain involved in motor coordination and balance.\",\n      \"relevance\": \"The report notes normal tracer uptake in the cerebellum.\",\n      \"relation\": \"See above.\"\n    },\n    {\n      \"term\": \"hypothesis\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"A proposed explanation or assumption used to guide investigation or assessment.\",\n      \"relevance\": \"The report presents a hypothesis related to the diagnosis and management of Alzheimer's disease.\",\n      \"relation\": \"See above.\"\n    },\n  ]\n)"
    }
}